Technical Analysis for NMRD - Nemaura Medical Inc.

Grade Last Price % Change Price Change
D 7.38 2.22% 0.16
NMRD closed up 16.26 percent on Monday, March 1, 2021, on 73 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Flat
Historical NMRD trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 2.22%
Wide Bands Range Expansion 2.22%
Oversold Stochastic Weakness 2.22%
Wide Bands Range Expansion 18.84%
Oversold Stochastic Weakness 18.84%
Fell Below 20 DMA Bearish 5.13%
Narrow Range Bar Range Contraction 5.13%
Stochastic Reached Oversold Weakness 5.13%
Wide Bands Range Expansion 5.13%
Oversold Stochastic Weakness 5.13%
Older End-of-Day Signals for NMRD ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 1 hour ago
Rose Above 10 DMA about 1 hour ago
Up 2% about 1 hour ago
Rose Above Previous Day's High about 2 hours ago
10 DMA Resistance about 2 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Nemaura Medical Inc. Description

Nemaura Medical, Inc. is a holding company. The Company owns a diagnostic medical device company specializing in discovering, developing and commercializing specialty medical devices. The Company's focus is on the development of a continuous glucose monitoring (CGM) device, which consists of a disposable patch containing a sensor, and a non-disposable miniature electronic watch with a re-chargeable power source. CGM through a non-invasive patch can enable early detection of subtle changes in blood glucose levels. The Company, through its operating subsidiaries, performs medical device research and manufacturing of a CGM, named sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes, and may also be used to screen pre-diabetic patients. The sugarBEAT device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Diabetes Medical Devices Wireless Device Endocrine System Glucose Diabetes Mellitus Blood Tests Endocrinology Medical Monitoring Blood Glucose Monitoring I Diabetes Ii Diabetes Continuous Glucose Monitor Blood Sugar Level

Is NMRD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 16.5
52 Week Low 3.12
Average Volume 270,068
200-Day Moving Average 5.72
50-Day Moving Average 5.55
20-Day Moving Average 7.48
10-Day Moving Average 7.34
Average True Range 0.84
ADX 44.51
+DI 32.58
-DI 20.23
Chandelier Exit (Long, 3 ATRs ) 10.07
Chandelier Exit (Short, 3 ATRs ) 6.67
Upper Bollinger Band 9.92
Lower Bollinger Band 5.04
Percent B (%b) 0.45
BandWidth 65.34
MACD Line 0.43
MACD Signal Line 0.68
MACD Histogram -0.2532
Fundamentals Value
Market Cap 165.4 Million
Num Shares 22.9 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -300.83
Price-to-Sales 0.00
Price-to-Book 7.91
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.62
Resistance 3 (R3) 8.47 7.86 8.38
Resistance 2 (R2) 7.86 7.50 7.93 8.30
Resistance 1 (R1) 7.54 7.29 7.70 7.69 8.23
Pivot Point 6.93 6.93 7.01 7.00 6.93
Support 1 (S1) 6.61 6.57 6.77 6.76 6.21
Support 2 (S2) 6.00 6.36 6.07 6.14
Support 3 (S3) 5.68 6.00 6.06
Support 4 (S4) 5.83